Dyadic International, a biotech company specializing in protein production, will announce its Q3 2026 financial results on November 12, 2026. The company will also host a conference call to discuss the results and provide a corporate update. Investors can join the call via phone or webcast, with a replay available afterward on Dyadic's website. This event is important for stakeholders to assess Dyadic's progress and outlook in the biotech sector.
Dyadic International's upcoming Q3 2026 financial results provide context for health-sector market activity on Pluang. As of Oct 31, 2026 03:11 WIB, out of 150 priced health-sector US stocks, 51 rose and 99 fell. Notably, DNA (Ginkgo Bioworks Holdings Inc) dropped 13.42% to USD 11.03 with 83% of Pluang orders buying and a typical hold time of 8 days, contrasting with REGN (Regeneron Pharmaceuticals Inc) which rose 13.16% to USD 926.50 despite 64% sell orders and a much longer hold time of 108 days.
Mohawk Industries announced a new $500 million stock buyback program alongside strategic guidelines focusing on strengthening market position, driving innovation, improving profitability, and disciplined capital allocation. The company plans to inves...
3E Network Technology Group Limited received a notice from Nasdaq that its Class A shares will be delisted due to the share price falling below $1.00 for 30 consecutive business days. The company is not eligible for a compliance period because of a r...
Philips has introduced the HyperVue Integrated System in the U.S., a fixed, single-room setup combining DeepOCT+NIRS imaging with X1-FFR physiology assessment for coronary interventions. This system is designed to streamline cath lab workflows by kee...
Atlas Copco Group completed Expansion Week in the US, unveiling three major manufacturing expansions in New York and South Carolina. The new facilities will increase production of oil-free compressors, dry vacuum pumps, and gas and process equipment,...
Mohawk Industries reported Q3 2026 net sales of $2.8 billion, up about 1%, driven by price increases offsetting lower volumes amid weak demand. Adjusted EPS rose 2% to $2.72, supported by productivity and pricing strategies. The company generated $39...
